bf/NASDAQ:SNSE_icon.jpeg

NASDAQ:SNSE

Sensei Biotherapeutics, Inc.

  • Stock

USD

Last Close

1.08

28/03 20:00

Market Cap

20.00M

Beta: −0.20

Volume Today

16.94K

Avg: 84.31K

PE Ratio

−0.55

PFCF: −0.57

  • industry

    Biotechnology
  • exchange

    NASDAQ Global Market
  • website

    www.senseibio.com
  • ipo date

    Feb 04, 2021
  • full time employees

    28
  • currency

    USD

Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused...Show More

Earnings

Earnings per Share (Estimate*)

-3-2.5-2-1.5-1-0.50.52019-12-312021-03-252022-03-102023-03-282024-03-26

Revenue (Estimate*)

0.000.000.010.010.012019-12-312021-03-252022-03-102023-03-282024-03-26

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.